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Abstract 
Objectives 
Positive mood has been associated with enhanced immune function. Interventions that 
improve mood could, therefore, provide a mechanism for optimising immune related 
health outcomes. Brief interventions that improve mood, also known as mood 
inductions, potentially offer a pragmatic approach to enhancing immune function for 
finite periods where this would be beneficial to health (e.g., in advance of vaccination 
or surgery). This review sought to systematically examine the evidence regarding the 
effects of brief, single-session positive mood interventions on immunity. 
Methods 
Systematic searches of electronic databases were performed from earliest records to 
25th July 2018. We identified 42 interventions suitable for inclusion, six of which were 
tested in multiple sub-populations. Random effects meta-analyses were performed for 
pre-post experimental group immune outcomes measured in at least 5 intervention 
studies.  
Results 
While interventions were heterogeneous, 81% resulted in a statistically significant 
change in at least one immune parameter following the positive mood intervention for 
one or more of the sub-populations examined. However, studies were, in general, of 
low-to-moderate quality with small sample sizes (median n=32) and did not examine 
the persistence, or clinical relevance of the immune changes observed. Random 
effects meta-analyses showed a significant medium-sized effect of interventions on 
increasing secretory IgA concentration (g=0.65), a small but statistically significant 
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effect for increased IL-6 production (g=0.12) and non-significant effects on NK cell 
activity (g=0.15). 
Conclusions 
The current literature provides modest evidence that improvements in mood resulting 
from brief interventions can influence some immune parameters in ways indicative of 
enhanced immune function. However, there is a need for higher quality research in 
this area that focuses on clinically relevant immune outcomes and mechanisms.  
 
Keywords: Positive affect, immunity, intervention, positive mood, systematic review, 
meta-analysis 
 
Abbreviations: s-IgA = Secretory immunoglobulin serotype A; MeSH = Medical 
subheadings; EPHPP = Effective Public Health Practice Project; IL-6 = Interleukin 6; 
NK = Natural killer cell; RCT = Randomised Controlled Trial 
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1. Introduction 
Research exploring links between psychological experiences, immunity, and health 
has historically been dominated by a focus on the effects of negative emotions such 
as stress, depression, and loneliness (1). While an imbalance still exists, over the past 
two decades growing interest in positive psychology has resulted in an accumulation 
of evidence that positive affective states (e.g., happiness, joy) and dispositions can 
beneficially contribute to health outcomes including those which may have 
immunological aetiologies (2–7).  
 
Multiple biological pathways between sub-cortical regions of the brain responsible for 
affective processing and the immune system have been described including endocrine 
and cytokine-mediated inflammatory routes (5) as well as the direct autonomic 
innervation of primary and secondary lymphatic organs extending from the central 
nervous system (8–10). Numerous observational and experimental studies provide 
strong evidence for a direct relationship between greater positive affect and enhanced 
immune function. For example, in a prospective longitudinal diary study, secretory 
immunoglobulin A (sIgA) response to rabbit albumin was found to be enhanced on 
days where participants reported greater positive mood (11). Viral challenge studies 
have shown reduced susceptibility to infection in those with more positive affective 
styles (12,13) and higher levels of trait positive affect has been associated with 
enhanced Hepatitis B vaccination responses (14). Together, these data suggest 
boosting positive affect could potentially act as an ‘immune enhancer’ in clinically 
meaningful ways. 
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While long-term improvements in positive affect levels, and therefore as a result 
immune function, are self-evidently desirable; interventions that target prolonged 
mood change face considerable barriers in being widely adopted. While there is some 
sparse evidence that positive affect intervention studies can achieve long term mood 
benefits (15) – to date, such interventions have required multiple interactive sessions 
with trained professionals, completed over a period of weeks and considerable 
participant dedication. This makes them expensive and somewhat burdensome for 
healthcare providers.  
 
An alternative and arguably more pragmatic approach to exploiting the relationship 
between mood and immune function involves targeting brief positive mood 
interventions (also known as positive mood inductions) at particularly salient time-
points where enhanced immune function for finite periods may be beneficial. For 
example, immediately prior to vaccination or in advance of surgery. Positive mood on 
the day of vaccination has been associated with enhanced antibody responses to 
some strains of influenza vaccination (16) and brief relaxation has been shown to 
improve clinical wound healing in surgical patients (17). There is also considerable 
body of evidence showing more negative emotional states to be associated with 
poorer immune function (18), wound healing (19), and surgical recovery (20). Brief 
interventions, that induce positive mood (or reduce negative mood), could be expected 
to be relatively cheap to implement and could, therefore, potentially be incorporated 
into healthcare settings where interactions are also, generally, brief.  
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In this paper we systematically review and meta-analyse the evidence that mood 
improvements resulting from brief, single session interventions are related to 
immunity. The primary aims of this review are to (1) identify the size and nature of the 
existing literature base relating to brief mood-enhancing interventions and immunity, 
(2) to assess the quality of this literature, and (3) examine the impact of mood 
enhancing interventions on immunological outcomes.  
 
2. Method 
 
2.1.  Search Strategy 
Systematic electronic searches were conducted of EMBASE, PsycINFO, 
PsycARTICLES, and MEDLINE from earliest records to 25th July 2018. A 
comprehensive overview of the search terms employed can be found in the 
supplementary appendix. In brief, the searches included synonym terms relating to (1) 
intervention/manipulation (e.g., modulat*, induc*) (2) mood (e.g., emotion*, happ*), 
and (3) immunity (e.g., immun*, cytokine*).  Medical subheadings (MeSH) were used 
when possible.  Reference lists of included articles and previous reviews of potential 
relevance (21–27) were hand-searched to identify additional articles not picked up by 
the electronic searches. 
 
2.2.  Inclusion and Exclusion criteria 
English language studies appearing in a peer-reviewed journal, presenting primary 
research, reporting a single session intervention measuring changes in mood and 
some aspect of immunity were included. Immune outcomes needed to be assessed 
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both immediately pre- and post-intervention for a study to be included, with any later 
follow-ups also included. Studies which did not include an appropriate mood 
manipulation check (i.e., measure whether participants mood changed as a result of 
the intervention), physical activity interventions, or studies that examined recovery 
from a stressor or negative mood inductions following intervention were excluded, as 
these were deemed to preclude clarity on whether any immunological changes were 
driven by the interventions proposed mediating mechanisms (mood-enhancement) or 
other factors (e.g., physical exertion, distraction from prior stressor). Negative mood 
inductions and ‘neutral’ interventions acting as a control group (e.g., rest, reading) 
were not included. Studies focusing exclusively on endocrine outcomes (e.g., cortisol), 
animal studies, and conference proceedings were also excluded.  
 
2.3. Quality Assessment 
Study quality was assessed using the Effective Public Health Practice Project 
(EPHPP) quality assessment tool for quantitative studies (28). The EPHPP is designed 
to assess quality for any quantitative study design and assesses six primary domains: 
selection bias, study design, confounders, blinding, data collection method, and 
withdrawals/dropouts. Each of these domains is graded individually as strong, 
moderate, or weak which are then combined into an overall global rating. A study 
receives a global rating of ‘Strong’ if none of the six individual domains are graded as 
weak, ‘Moderate’ if only one is coded as weak, and ‘Weak’ if two or more domains are 
assessed as weak. The EPHPP also includes items relating to intervention integrity 
and analyses – however, as these are not used to assessing the global rating of study 
quality they were not assessed in the present review. The tool is recommended by the 
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Cochrane Collaboration as an alternative to their own risk of bias tool that is primarily 
designed for randomised controlled trials (29).  
 
2.4. Statistical Analysis 
Calculation of effect sizes (Hedges’ g) for pre-post experimental group outcomes and 
random effects meta-analyses were conducted using comprehensive meta-analysis 
version 3 (Biostat, Englewood, NJ; Internet: https://www.meta-analysis.com/). Due to 
concerns regarding the accuracy of effect size estimation in meta-analyses containing 
very few low-to-moderate quality studies, meta-analyses were only performed on 
immune outcomes measured in at least 5 interventions [secretory IgA (s-IgA) 
concentration, natural killer cell activity (NK activity), and interlukin-6 (IL-6) production]. 
Population subgroups (e.g., carers, patients) were included separately in meta-
analyses when presented as such in the published article. Where available, 
unadjusted pre/post-vaccination means, standard deviations, and pre-post 
correlations were preferentially used to calculate effect sizes. However, where these 
were not available: change scores, and paired p and t-test values (with no-covariates 
included) were also used. As pre-post correlations are rarely reported, where pre-post 
correlations were unknown we calculated effect sizes assuming a positive correlations 
of .25, .5, and .75 as described by Norris et al. (30). As these assumptions yielded 
very similar meta-analytic effect size estimates, the findings reported in this paper are 
based on a correlation of .5 (analyses assuming correlations of .25 and .75 are 
available upon request). Where insufficient information to calculate effect sizes was 
available, attempts were made to contact authors to provide additional information. In 
total attempts were made to contact the authors of 18 articles for some form of 
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additional information with a further 2 contacted for reasons of clarification. Of these, 
authors from 4 articles were able to provide the requested information, 6 responded 
but were unable to provide the data required, and 10 did not respond. Where immune 
outcomes were assessed at multiple dilutions, these were combined into a mean 
composite effect size for that outcome. Variation between effect sizes was assessed 
using Cochran’s Q test with significant heterogeneity indicated by a p-value <.1, and 
the percentage of no-chance heterogeneity assessed using the I2 Statistic (31). To 
examine whether the magnitude of the interventions effect on mood outcomes was 
associated with the magnitude of immune effects, post-hoc exploratory meta-
regressions were performed. Where multiple measures of mood were reported, these 
were combined into a mean composite mood effect size (this included measures 
shown to not be significantly different post-intervention). 
 
3. Results 
3.1. Study Selection Process 
The flow of studies through the review process is presented in Figure 1Error! 
Reference source not found.. Ultimately, 31 articles (hereafter designated ‘k’), 
reporting 42 interventions (hereafter designated ‘i’) were identified as suitable for 
inclusion in the review. Six of the interventions were examined and compared in two 
or more distinct sub-populations (e.g., older vs younger adults). The most common 
reasons for exclusion from the 168 articles identified for full-text examination were the 
intervention lasting longer than a single session (n = 47) and not including an 
appropriate manipulation check (n = 30). 
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[INSERT FIGURE 1 HERE] 
 
3.2.  Studies Characteristics 
The most common origin of studies was the USA (k=13), with a large number from 
Japan (k=12). The remaining studies were conducted in the UK (k=2), Canada, 
Australia, South Korea, and Israel (all k=1). Most commonly studies adopted a 
crossover design (k=15; 48.4%), with participants receiving more than one intervention 
(with a gap between) in a randomised order. Eleven studies were randomised 
controlled trials and five adopted a cohort design. Sample sizes were generally small, 
ranging from 5 to 193 with a median of 32 (mean 39.7). Participants were most 
frequently adults self-selected from the general population (k=17; 54.8%) although a 
substantial proportion recruited from exclusively student samples (k=5; 16.1%). Only 
one study explicitly recruited older adults (32), with one study conducted in children 
(33). The remaining studies recruited from more specific populations including singers, 
method actors, couples or patient groups with an existing health condition. 
 
3.3.  Intervention Characteristics 
Interventions were varied, although the most common was a comedy film or audiotape 
(i=7; 16.6%). Massage (i=6), listening to (i=4) or making music in the form of group 
drumming (i=4) or singing (i=1) were also popular intervention forms. The remaining 
interventions included pleasant or memory retrieving odours (i=6), relaxation with or 
without immune suggestions (i=4), acting out an imagined positive experience (i=3), 
Qi therapy + rest (i=2), mental recall of positive autobiographical events, watching film 
clips of attractive celebrities, hugging and kissing a romantic partner, receiving a 
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footbath and writing about self-congruencies (all i=1). The majority of interventions 
were administered on an individual basis (i=26; 61.9%) with the remaining delivered 
in group settings (i=12) or in couples (i=1). No information was reported as to the 
nature of intervention administration in three cases. Interventions ranged from 90 
seconds to 120 minutes in duration (mean= 48 mins, median= 40 mins).  
 
3.4. Quality Assessments 
A summary of quality assessment ratings for each of the EPHPP individual domain 
and global quality ratings are shown for each study in Table 1. In terms of global quality 
ratings, 1 study was classified as strong, 20 as moderate, and 10 as weak. This is 
suggestive of weak-to-moderate overall quality for this literature. Further examination 
of the individual quality domains shows selection bias was an issue for nearly all 
studies. In the selection bias domain, all but one study was classified as weak, 
indicating participants were either self-selecting or that the sample selection processes 
were not adequately reported, with one classified as strong. In the study design 
domain, eleven studies where classified as strong (indicating they classified as RCTs 
or clinical controlled trials), 20 as moderate, and none as weak. Confounders were 
often controlled for by the crossover nature of many study designs resulting in 23 
studies being classified as strong in this domain, none as moderate, and 8 identified 
as weak. All studies received a moderate rating for the blinding domain, in most cases 
because assessor and participant blinding was not mentioned. However, it is worth 
noting that changes made to the EPHPP tool coding instructions after initial quality 
assessments were made would require studies with insufficient reporting of blinding 
to be coded as weak. With regards to the data collection method, 10 studies were 
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categorised as strong - meaning that outcome measures (immune) had been 
demonstrated as both valid and reliable – with the remaining 21 studies classified as 
moderate due to not reporting reliability statistics for the outcome measures or failing 
to refer to previous reports of the measure’s reliability. Most studies reported minimal 
or no attrition during the studies, meaning that for the withdrawals and dropouts 
domain 28 studies were classified as strong, none as moderate, and only three as 
weak. 
 
3.5. Narrative Synthesis 
In total, the 42 interventions were examined across a total of 50 groups (e.g., those 
with and without a specific health condition; older vs younger adults). Of these, a 
statistically significant improvement from pre- to post-intervention in at least one mood 
outcome was observed in 46 (92.0%) of the groups examined. Of those not showing 
a significant mood improvement, two interventions [listening to music for 15 minutes 
(34), and a back rub (35)] showed a reduction in state anxiety in the predicted direction, 
but this was not statistically significant. The remaining two [primed and unprimed 
exposure to a lavender odour (36)] showed a decrease in positive affect following the 
interventions.  
Most studies measured multiple immune outcomes (k=21; 67.7%), with none of these 
identifying a primary immune outcome. The number of immune outcomes ranged 
across studies from 1 to 19, with a mean of 5 per study (median=3). The most common 
immune outcome measures related to secretory IgA (s-IgA) concentration/flow rate 
(i=17), natural killer (NK) cell count or activity (i=12) and Interleukin-6 (IL-6) production 
(i=10). Secretory IgA is a class of antibody, most typically measured in saliva, which 
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acts as a first line of defence against pathogens on mucosal surfaces. Natural killer 
cells are critical components of the innate immune system with multiple functions 
including providing rapid, cytotoxic responses to kill viral-infected cells. NK-cells were 
measured both enumeratively and in relation to their activity/function in response to 
stimulation ex-vivo. Interleukin-6 (IL-6) is a pro-inflammatory cytokine (chemical 
messenger) that can be produced by, and influence the function of, multiple immune 
cells including antibody secreting B cells. Other immune outcomes were only 
measured in a few or single studies. 
 
Table 2 summarises the findings of studies included in the review. Most interventions 
resulted in at least one observed significant immunological change in at least one 
tested population (i=34; 81.0%). Considering the four groups in whom interventions 
did not induce a statistically significant improvement in mood outcomes: two which 
showed non-significant improvements in state anxiety reported increased s-IgA 
concentration and IL-1 respectively; with the two showing decreases in positive affect 
also showing reduced wheal sizes in the delayed hypersensitivity to Canadia testing 
compared to controls, indicating a more blunted immune response.   
  
Of the 17 interventions in which s-IgA was measured, fourteen resulted in a significant 
increase in s-IgA concentration or flow rates in all sub-populations examined (33,37–
44), two reported no effects (37,45), and one demonstrated an increase in s-IgA 
concentration but did not assess the significance of the change (45). Of the two 
interventions that resulted in no significant change, one was a 90-minute music 
improvisation group in cancer patients and the other was among students who were 
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encouraged to express their emotions while watching a comedy film. Both of these 
interventions had very small samples (number of participants receiving the 
intervention: nine and eight respectively). 
 
Of the 12 interventions in which some aspect of NK cell count or activity was 
measured, findings were less consistent: with six interventions demonstrating 
increased NK cell counts or activity following the intervention (46–50), five finding no 
effect (32,51–54), and one finding no significant changes in NK cell activity from before 
to immediately after the intervention, but significantly greater increases when 
compared with the control group (55). When comparing interventions which showed 
an increase in NK cell count or activity to those which did not, no clear differences 
were evident in terms of intervention type, length, or study size. 
 
Of the 10 interventions in which IL-6 production was measured, only one study sub-
population showed significant increases in IL-6 following the intervention (32 - older 
adults), with the remainder showing no significant changes (32 - younger 
adults,36,56–60). 
 
3.6. Meta-Analyses of Immunological Outcomes 
Broadly speaking, meta-analyses mirrored the findings of the above narrative 
synthesis. For s-IgA concentration outcomes, 12 pre- to post-intervention comparisons 
(including general population and cancer patient sub-populations from Noto et al. 
2010) had sufficient data for inclusion in a meta-analysis (see Figure 2). Pooling these 
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in a random effects meta-analysis produced an overall significant medium positive 
effect size of 0.65 (95%CI: 0.50, 0.80) indicating greater s-IgA concentrations post-
intervention. Examination of Cochran’s Q and the I2 Statistic indicated low but non-
significant heterogeneity [Q(11) = 12.37, p = .337; I2 = 11.04%]. 
 
[INSERT FIGURE 2 HERE] 
 
For NK cell activity, effect sizes could be calculated for seven pre- to post-intervention 
comparisons (including younger and older adult sub-populations from Koyama et al. 
2009). Pooling these in a random effects meta-analysis produced a small but non-
significant positive effect size of 0.15 (95%CI: -.05, .34) indicating greater, but not 
significantly greater NK cell activity post-intervention (see Figure 3). Examination of 
Cochran’s Q and the I2 Statistic indicated low but non-significant heterogeneity [Q(6) 
= 8.03, p = .24 ; I2 = 25.3%]. 
 
[INSERT FIGURE 3 HERE] 
 
For IL-6 production, 11 pre- to post-intervention comparisons (including carer, patient 
and bereaved carer sub-populations from Fancourt et al. 2016, primed and unprimed 
sub-populations from Kiecolt-Glaser et al. 2008, and younger and older adult sub-
populations from Koyama et al. 2009) had sufficient data for inclusion in a meta-
analysis (see Figure 4). Pooling these in a random effects meta-analysis produced a 
small but significant positive effect size of 0.12 (95%CI: .02-.23) indicating greater IL-
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6 production post-intervention. Examination of Cochran’s Q and the I2 Statistic 
indicated moderate, but not significant heterogeneity [Q(10) = 17.03, p = .074 ; I2 = 
41.29%]. Examination of the forest plot suggested a comparatively high effect size for 
the only older adult sub-population included in the analysis (Koyama et al. 2009) may 
account for much of the heterogeneity observed. When this subpopulation was 
excluded from the meta-analysis, the pooled effect size reduced but remained 
significant at 0.10 (95%CI .01-.17) with no notable heterogeneity [Q(9) = 7.70, p = .57; 
I2 = 0%]. 
 
[INSERT FIGURE 4 HERE] 
 
3.7. Post-hoc Exploratory Meta-Regressions with Mood as Moderating Variable 
Meta-regression analyses were conducted to examine whether the magnitude of the 
interventions effect on mood outcomes was associated with the magnitude of immune 
effects for those outcomes above found to significantly change from pre- to post-
intervention in pooled meta-analyses (s-IgA and IL-6 production). A detailed 
description of these results and limitations of this approach are presented in the 
supplementary appendix. In brief, meta-regression analyses showed that for s-IgA 
concentration, when one outlying study (61) with an exceptionally high reported mood 
effect size (Hedges’ g = 7.65, all others studies Hedges’ g < 1.8) was excluded from 
the analysis, s-IgA effect sizes were significantly associated with mood effect sizes 
[Q(1) = 4.68, p = .031]. This relationship was such that larger increases in s-IgA 
concentration were seen following interventions which induced larger improvements 
in mood. For IL-6 production, the results suggested no significant relationship between 
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mood and IL-6 effect sizes [Q(1) = 0.31, p = .581]. Given the few studies amenable for 
inclusion in these analyses, the subsequent low power, and the heterogeneity of the 
included interventions, these analyses should be considered with due caution. 
 
4. Discussion 
The present review was conducted to identify and assess the existing literature relating 
to the effects on immunity of brief interventions that enhance mood. Specifically, the 
review aimed to identify the size and nature of the existing literature base, assess the 
quality of this literature, and examine the impact of mood enhancing interventions on 
immunological outcomes. Findings relating to each of these aims are discussed in turn 
below, with areas in need of further research highlighted. 
 
4.1. Size and Nature of the Literature 
The review identified a moderate-sized literature of 31 articles presenting one or more 
brief mood-improving interventions and measuring an aspect of immunity. Only eleven 
studies were RCTs. In contrast, the majority adopted crossover or cohort designs, 
which are generally considered less rigorous tests of an intervention than RCTs (62). 
Sample sizes were, in general, relatively small – indicating the need for larger RCTs 
in the future. Nearly all studies only examined immune changes immediately post-
intervention, with only two studies measuring aspects of immunity in a later follow-up. 
As such, there is very little evidence regarding the extent to which brief mood-
enhancing interventions have persistent effects on immunity. Such evidence is needed 
to determine how close to an immune challenge (e.g., vaccination, surgery) an 
intervention would need to be delivered to be effective, and whether this differs 
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according to the intensity or duration of positive affect induced. Evidence from a recent 
meta-analysis on induced stress has shown that brief laboratory stressor exposures 
can result in changes to cytokine profiles that persist up to 120 minutes following stress 
exposure (63). However, whether similar persistence of immune effects accompany 
the induction of positive mood remains unclear.  
 
4.2. Intervention Characteristics 
A heterogeneous selection of interventions was identified. Many of the interventions 
lasted 60 minutes or longer, making them poor candidates for some health care 
settings where encounters may be brief (e.g., primary care). However, interventions 
less than 5 minutes in duration showed some evidence of immune effects and may be 
more suitable for such contexts. Further research is needed relating to the minimum 
required length of a positive mood intervention to induce immune changes. Several 
interventions relied on specialist equipment (e.g., odour generation) or skilled 
facilitators (e.g., massage, group drumming) that would likely make such interventions 
relatively costly to implement, giving them limited potential for widespread 
implementation. In contrast, some non-specialist intervention forms including watching 
or listening to a comedy programme, mental recall of positive memories, and listening 
to music may have greater implementation potential due to their comparative ease of 
administration.  
 
The vast majority of studies included in this review focused on healthy young adults, 
with only one study explicitly recruiting older adults (32) and one including children 
(33). Further, only a handful of studies focused on those with significant medical 
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illnesses, primarily cancer. Given the relative immunological naivety of children 
compared to young adults, the wide-ranging decline in immunological competence 
known to occur in later life (64,65) and immune alterations observed in some chronic 
illnesses (66), it is unclear whether any immune enhancing effects of brief mood 
improving interventions shown in younger adults are generalisable to these 
populations. Indeed, in the one study that compared older and younger adult cohorts 
(32), only the older adults saw immunological benefits following the intervention. 
Further research in children and older adults, both with and without significant medical 
illnesses would be beneficial, in particular exploring whether mood-enhancing 
interventions have larger immunological effects in these populations. 
 
4.3. Quality of the Literature 
Overall study quality in the reviewed literature was weak-to-moderate, with nearly all 
studies at risk of selection bias. Future studies in this area would benefit from more 
directed recruitment strategies, to ensure participants are representative of the target 
population. When considering the other domains assessed by the EPHPP study 
quality instrument, the reviewed studies were typically well designed to control for 
potential confounding factors and, due to their brief nature, showed little evidence of 
problematic attrition. Reporting standards were however generally poor, with few 
studies providing details about recruitment processes, study blinding, the reliability of 
immunological outcome measures, or providing sufficient details to allow future 
inclusion in a meta-analysis. Attempts made to obtain further details from authors were 
not always successful, thus limiting the number of studies that could be included in the 
meta-analytic portion of this review. Calls made over recent decades, across research 
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domains, to improve recording standards (67–69) appear to have had little impact in 
this area thus far.  
 
Looking beyond the included studies, it is noteworthy that a many potentially relevant 
articles were excluded from the present review because they had not measured mood 
before and after the intervention. The absence of appropriate manipulation checks 
limits the insight that can be gained from these studies, as it is not possible to ascertain 
whether any immunological changes resulting from the interventions are related to 
mood enhancement or some other factor. Future studies in this area should consider 
the inclusion of an appropriate manipulation check as essential (70). 
 
4.4. Impact of Brief Interventions on Immunity 
Despite the weaknesses in this literature, the substantial majority (34 of 42; 81.0%) of 
interventions included in this review were associated with at least one significant 
immunological change in one or more of the sub-populations assessed. Two 
interventions that actually resulted in a reduction in positive affect, correspondingly 
also resulted in blunted immune responses compared to controls. This consistency, 
regardless of the specific intervention employed, gives credibility to the hypothesis that 
brief positive mood-enhancing interventions could induce short-term immunological 
change in ways relevant to health. However, it is critical to note that most studies 
included measures of multiple immune parameters, did not specify a primary immune 
outcome, and did not adjust for multiple comparisons. As such, the possibility of false-
positive associations being found was high.  
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A causal relationship between positive mood improvements and immune function is 
partially supported by the exploratory meta-regression analysis on s-IgA outcomes, 
which suggested a dose-response relationship between positive mood and s-IgA 
changes. However, given the exploratory nature of this analysis and high 
heterogeneity of included studies, these findings (and the related null-effects found for 
IL-6) should be interpreted with due caution.  
 
Most of the immunological changes observed were broadly framed by authors as 
indicative of enhanced immune function following positive mood induction. However, 
a significant limitation is that the clinical relevance of these immunological changes 
was not effectively demonstrated in any of the included studies. For example, no 
studies included in this review investigated the effects of a mood-enhancing 
intervention on response to an administered in-vivo immune challenge (e.g., 
vaccination) or related to a clinical outcome (e.g., recovery from surgery). Indeed, all 
but one study (71) considered non-specific markers of immunity. While some of the 
immune parameters measured form part of the cascade of innate and adaptive 
immunological processes that follow antigenic challenge (e.g., cytokines, NK cells), 
due to the redundancy and complexity inherent in the immune system, it is hard to 
determine the importance of changes to individual components measured in isolation, 
to real-world clinical outcomes. While increases in non-specific aspects of immunity 
may be indicative of enhanced in-vivo immune responses to challenge (72,73), there 
is a clear need for future research to move away from a reliance on non-specific 
indices of immunity.  
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4.5. Strengths and Limitations 
The present review did not exclude studies on the basis of design-type to maximise 
the identification of relevant research evidence and the quality of included studies were 
assessed using an established standardised tool. However, this review did not seek 
to retrieve and include relevant unpublished articles (the so-called grey literature). The 
rationale behind this omission is that unpublished articles have not successfully gone 
through the peer-review process – thus, it is not possible to be certain of the articles 
quality and veracity. Yet, it is important to acknowledge that in excluding this literature 
the influence of any publication bias could be exacerbated – as interventions 
demonstrating no immune effects may have been less likely to be published.  
 
It is noteworthy that short bouts of physical exertion (e.g., bicycling) can result in 
positive mood improvements, as well as immune function changes (see 74). However, 
in this review we excluded such interventions to minimise the potential confounding 
effects of the physiological exertion on the relationship between positive mood 
changes and immunity. Yet, while most interventions were fairly passive (e.g., 
watching a comedy film) some included interventions involving some degree of 
physical effort (e.g., choir singing, drumming), thus it is not possible to completely 
disentangle whether any observed immunological changes in these studies result 
solely from the change in mood, or the physical consequences of the interventions 
(e.g., changes in respiration, increased bodily movement).  
 
5. Concluding Remarks 
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Brief interventions that improve mood can influence some immune parameters in ways 
which may be indicative of enhanced function. However, there is a need for higher 
quality, more methodologically rigorous, and better reported research in this area 
before firm conclusions can be drawn. As the literature reviewed was rated as low-to-
moderate quality and somewhat heterogeneous, the degree of confidence in the 
pooled findings are correspondingly modest. Currently there is a paucity of evidence 
regarding the clinical importance of mood-induced immunological change, its 
persistence, or its relevance beyond young adult populations.  
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Figure Captions 
 
Figure 1: PRISMA flow diagram of study selection process 
 
Figure 2: Forest Plot of Meta-analysis for Pre-Post Effect Sizes on S-IgA 
 
Figure 3: Forest Plot of Meta-analysis for Pre-Post Effect Sizes on NK Cell Activity 
 
Figure 4: Forest Plot of Meta-analysis for Pre-Post Effect Sizes on IL-6 Production 
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Figure 1: PRISMA flow diagram of study selection process 
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Figure 2: Forest Plot of Meta-analysis for Pre-Post Effect Sizes on S-IgA 
 
Study name Intervention Outcome Statistics for each study Hedges's g and 95% CI
Hedges's Lower Upper Standard 
g limit limit error
Burns et al. 2001 Music - Listening S-IgA 0.942 0.172 1.712 0.393
Donoyama & Shibasaki 2010 Massage - Freshman S-IgA 1.012 0.221 1.803 0.403
Donoyama & Shibasaki 2010 Massage - Instructor S-IgA 0.460 -0.196 1.115 0.335
Donoyama & Shibasaki 2010 Massage - Sophomores S-IgA 1.153 0.317 1.989 0.426
Donoyama et al. 2010 Massage S-IgA 1.072 0.459 1.685 0.313
Noto et al. 2010 - Cancer Patients Massage S-IgA 0.422 0.052 0.793 0.189
Noto et al. 2010 - General Massage S-IgA 1.106 0.485 1.727 0.317
Pawlow & Jones 2005 Relaxation Training S-IgA 0.667 0.334 1.000 0.170
Rider et al. 1990 Music + Immune Imagery S-IgA 0.365 0.068 0.663 0.152
Rider et al. 1990 Music + Unguided Imagery S-IgA 0.564 0.190 0.939 0.191
Yamamoto & Nagata 2011 Footbath S-IgA 0.830 0.126 1.534 0.359
Groer et al. 1994 Back Rub S-IgA 0.711 0.212 1.210 0.254
0.646 0.497 0.796 0.076
-2.00 -1.00 0.00 1.00 2.00
Favours No Intervention Favours Intervention
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Figure 3: Forest Plot of Meta-analysis for Pre-Post Effect Sizes on NK Cell Activity 
 
Study name Intervention Outcome Statistics for each study Hedges's g and 95% CI
Hedges's Lower Upper Standard 
g limit limit error
Bennett et al. 2003 Comedy Film NK Cell Activity -0.131 -0.586 0.324 0.232
Bittman et al. 2001 Comedy Film Combined 0.419 0.053 0.784 0.187
Futterman et al. 1992 Acting Happinness NK Cell Activity -0.093 -0.797 0.610 0.359
Koyama et al. 2009 - Older Adults Music - Drumming NK Cell Activity 0.118 -0.250 0.486 0.188
Koyama et al. 2009 - Younger Adults Music - Drumming NK Cell Activity -0.081 -0.448 0.286 0.187
Matsunaga et al. 2008 Film NK Cell Activity 0.612 0.032 1.193 0.296
Wachi et al. 2007 Music - Drumming Combined 0.197 -0.229 0.624 0.218
0.147 -0.045 0.339 0.098
-2.00 -1.00 0.00 1.00 2.00
Favours No Intervention Favours Intervention
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Figure 4: Forest Plot of Meta-analysis for Pre-Post Effect Sizes on IL-6 Production 
 
Study name Interv ention Outcome Statistics for each study Hedges's g and 95%  CI
Hedges's Lower Upper Standard 
g limit limit error
Fancourt et al. 2016 - Bereaved Carers Singing IL-6 0.186 -0.055 0.426 0.123
Fancourt et al. 2016 - Cancer Patients Singing IL-6 0.044 -0.217 0.305 0.133
Fancourt et al. 2016 - Carers Singing IL-6 0.020 -0.208 0.249 0.117
Kiecolt-Glaser et al. 2008 - Primed Participants Odour - Lavender IL-6 0.159 -0.026 0.344 0.095
Kiecolt-Glaser et al. 2008 - Primed Participants Odour - Lemon IL-6 0.170 -0.085 0.424 0.130
Kiecolt-Glaser et al. 2008 - Unprimed Participants Odour - Lavender IL-6 0.200 -0.019 0.418 0.112
Kiecolt-Glaser et al. 2008 - Unprimed Participants Odour - Lemon IL-6 -0.031 -0.241 0.180 0.108
Koyama et al. 2009 - Older Adults Music - Drumming IL-6 0.773 0.345 1.201 0.218
Koyama et al. 2009 - Younger Adults Music - Drumming IL-6 -0.197 -0.581 0.186 0.196
Matsunaga et al. 2011a Odour IL-6 0.309 -0.096 0.713 0.206
Mittwoch-Jaffe et al. 1995 Comedy Film IL-6 0.032 -0.214 0.278 0.125
0.124 0.022 0.226 0.052
-2.00 -1.00 0.00 1.00 2.00
Favours No Intervention Favours Intervention
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Table 1: Summary of quality assessments 
Authors (Year of publication) Selection 
Bias 
Study 
Design 
Confounder
s 
Blinding Data 
Collection 
Method 
Withdrawals 
and 
Dropouts 
Global 
Rating 
Bartlett et al. (1993) Weak Strong Weak Moderate Moderate Strong Weak 
Bennet et al. (2003) Weak Strong Weak Moderate Strong Strong Weak 
Bittman et al. (2001) Weak Strong Weak Moderate Moderate Strong Weak 
Burns et al. (2001) Weak Moderate Strong Moderate Strong Strong Moderate 
Donoyama et al. (2010) Weak Moderate Strong Moderate Moderate Strong Moderate 
Donoyama & Shibasaki (2010) Weak Moderate Strong Moderate Moderate Strong Moderate 
Fancourt et al. (2016) Strong Moderate Strong Moderate Strong Strong Strong 
Futterman et al. (1992) Weak Moderate Strong Moderate Moderate Strong Moderate 
Futterman et al. (1994) Weak Moderate Weak Moderate Moderate Strong Weak 
Groër et al. (1994) Weak Strong Weak Moderate Moderate Weak Weak 
Hall et al. (1992) Weak Moderate Strong Moderate Moderate Strong Moderate 
Hewson-Bower & Drummond 
(1996) 
Weak Strong Strong Moderate Strong Strong Moderate 
Jung et al. (2006) Weak Strong Weak Moderate Moderate Strong Weak 
Kiecolt-Glaser et al. (2008) Weak Moderate Strong Moderate Moderate Weak Weak 
Kimiata (2004)  Weak Moderate Strong Moderate Strong Strong Moderate 
Knapp et al. (1992) Weak Moderate Weak Moderate Moderate Strong Weak 
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Authors (Year of publication) Selection 
Bias 
Study 
Design 
Confounder
s 
Blinding Data 
Collection 
Method 
Withdrawals 
and 
Dropouts 
Global 
Rating 
Koyama et al. (2009) Weak Moderate Weak Moderate Moderate Strong Weak 
Labott et al. (2010) Weak Strong Strong Moderate Strong Strong Moderate 
Lefcourt et al. (1990) Weak Moderate Strong Moderate Moderate Strong Moderate 
Matsunaga et al. (2008) Weak Moderate Strong Moderate Moderate Strong Moderate 
Matsunaga et al. (2011a) Weak Moderate Strong Moderate Strong Strong Moderate 
Matsunaga et al. (2011b) Weak Moderate Strong Moderate Moderate Strong Moderate 
Matsunaga et al. (2013) Weak Moderate Strong Moderate Strong Strong Moderate 
Mittwoch-Jaffe et al. (1995) Weak Strong Strong Moderate Moderate Strong Moderate 
Noto et al. (2010 Weak Moderate Strong Moderate Strong Weak Weak 
Pawlow & Jones (2005) Weak Strong Strong Moderate Moderate Strong Moderate 
Rider et al. (1990) Weak Strong Strong Moderate Strong Strong Moderate 
Strauman et al. (2004) Weak Moderate Strong Moderate Moderate Strong Moderate 
Takahashi et al. (2001) Weak Moderate Strong Moderate Moderate Strong Moderate 
Wachi et al. (2007) Weak Moderate Strong Moderate Moderate Strong Moderate 
Yamamoto & Nagata (2011) Weak Strong Strong Moderate Moderate Strong Moderate 
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Table 2: Summary of Included Studies 
Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Bartlett et al. 
(1993) 
USA 
RCT 
General 
Population 
20, NR (NR), NR, 
50% 
Listening to 
Music, 15 mins, 
Individual 
IL-1 (1) Note: Control condition comprised reading 
magazines. This study also included a separate 
experimental and control group who only had 
outcomes assessed at 24 hours post-intervention. 
Significant increase in IL-1 in those listening to 
music. No significant change in IL-1 among those 
in control group. 
Bennett et al. 
(2003)  
USA 
RCT 
General 
Population 
33, NR (NR), NR, 
100% 
Comedy film, 
NR, Group 
NK cell 
cytotoxicity (1) 
Note: Control condition comprised viewing a 
neutral film. 
No significant differences in NK cell cytotoxicity 
change between participants who viewed the 
comedy film compared to the control. 
 
Bittman et al. 
(2001) 
USA 
RCT 
General 
Population 
60; NR (NR); NR, 
48% 
Drumming; 60 
mins; Group 
NK cell activity 
x4 
concentrations; 
Lymphokine-
activated Killer 
Activity with IL-2 
x2 
concentrations  
Lymphokine-
activated Killer 
Activity with 
IFN-γ x2 
concentrations; 
Note: Control condition comprised reading quietly.  
Significant increases from before to immediately 
after intervention in Baseline for IFN-γ stimulated 
(both concentrations), Lymphokine-activated Killer 
Activity with IFN-γ (both concentrations). There 
were no significant changes in other immune 
outcomes. 
Compared to controls the intervention arm had 
significantly larger increases from before to 
immediately after the intervention in NK cell 
activity at effector to target ratio of 6:1; NK cell 
activity at effector to target ratio of 12:1; Baseline 
for IFN-γ stimulated at both concentrations and 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Baseline for 
IFN-γ stimulated 
x2 
concentrations; 
IL-2; IFN-γ; 
Leukocyte count 
(13) 
Lymphokine-activated Killer Activity with IFN-γ at 
both concentrations. There were no significant 
differences between groups in other immune 
outcomes. 
Burns et al. (2001) 
UK 
Crossover 
Cancer Patients, 
9, NR (NR), NR, 
67% 
a) Listening to 
live music, 60 
mins, Group 
b) Music 
improvisation, 
90 mins, Group 
 
S-IgA 
concentration; 
S-IgA secretion 
rate (2) 
S-IgA concentration and secretion rates increased 
significantly after intervention (a). No significant 
differences in immune outcome measures for 
intervention (b). 
Donoyama et al. 
(2010) 
Japan 
Crossover 
General 
Population (Post-
Menopausal 
Women), 17, 54.4 
(2.1), NR, 100% 
Massage, 40 
mins, Individual 
 
S-IgA 
concentration 
(1) 
Note: Control group rested for matched time on 
massage table 
S-IgA concentration increased significantly after 
both massage and rest. No significant differences 
between massage and rest on S-IgA 
concentration changes. 
Donoyama & 
Shibasaki (2010) 
Japan 
Crossover 
General 
Population (Post-
Menopausal 
Women), 10, NR 
(NR), NR, 100% 
a) Massage (by 
student with 6 
months 
training), 40 
mins, Individual 
b) Massage (by 
student with 15 
months 
S-IgA 
concentration 
(1) 
Note: Study included a control group who rested 
for matched time on massage table 
S-IgA concentration increased significantly after 
all interventions and control group. No significant 
differences between interventions on S-IgA 
concentration changes. 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
training), 40 
mins, Individual 
c) Massage (by 
instructor with 
>15 years 
experience), 40 
Mins, Individual 
 
Fancourt et al. 
(2016) 
UK 
Cohort 
Cancer Carers, 
Bereaved Carers, 
Cancer Patients, 
Cancer Carers: 
72, 56.9(13.6), 
NR, 80.6% 
Bereaved Carers: 
66, 59.7(11.5), 
NR, 81.8% 
Cancer Patients: 
55, 60.8(9.0), NR, 
80% 
Choir Singing, 
70 mins, Group 
IL-2, IFN-, 
TNF-, IL-4, IL-
6, IL-17, MCP1, 
sIL2r, sTNFr1, 
GM-CSF (10) 
Across time, significant increases in GM-CSF, IL-
2, IL-4, IL-17, TNF-, sIL-2r, and sTNFr1 after 
controlling for multiple comparisons. There were 
no significant differences across time for other 
immune outcomes. 
Between group comparisons showed sTNFr1 
significantly increased in both carer groups but 
not patients. MCP1 significantly increased in 
bereaved carers but not in other groups. IL-17 
significantly increased in bereaved carers and 
patients but not non-bereaved carers. No other 
significant between group differences for other 
immune outcomes. 
 
Futterman et al. 
(1992) 
USA 
Crossover 
Method Actors 
5, 31.2 (NR), 25-
38, 40% 
Acting out a 
happiness 
scenario, <120 
mins, Individual 
NK Cell Activity; 
CD-3; CD-4; 
CD-8; CD-16; 
CD56; CD57 (7) 
No significant changes in any of the immune 
outcomes from pre-to-post intervention. 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Futterman et al. 
(1994) 
USA 
Crossover with 
Control Group 
Method Actors 
(General 
Population 
Controls) 
Actors: 16, 35 
(NR), 24-47, 0% 
 
Controls: 9, 29.4 
(NR), 18-43, 11% 
a) Acting out a 
euphoric 
happiness 
scenario; 
<120 mins, 
Individual 
b) Acting out a 
relaxed 
happiness 
scenario; 
<120 mins, 
Individual 
NK cell 
cytotoxicity; 
Lymphocyte 
response PHA x 
2 concentration; 
CD-3%; CD-4%; 
CD-8%; CD-
16%; CD-56%; 
CD57% (9) 
Note: This study also included two negative mood 
induction conditions and a neutral condition.  
In all induced mood states (positive and negative 
combined) significant increases in CD-8%, CD-
16%, CD-56%, CD-57% and NK cell cytotoxicity 
from pre-to-post mood inductions. No significant 
effects on remaining immune parameters. 
Significant differential lymphocyte responses to 
high doses of PHA were observed between 
positive and negative mood inductions, with 
responses increased in both positive inductions 
but decreased in negative inductions. No 
differences in any other immune outcome. No 
immune outcomes changed in the control group. 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Groër et al. (1994) 
 
USA 
 
RCT 
 
General 
population 
middle-aged and 
older adults 
32, 65.8 (NR), 44-
77, 68.8% 
Back rub, 10 
mins, Individual 
S-IgA 
concentration; 
S-IgA secretion 
rate (2) 
Note: Control condition comprised 10 mins of bed 
rest. 
S-IgA concentration increased significantly more 
in those who received the back rub compared to 
controls. S-IgA secretion rate increased in both 
groups but did not significantly differ between 
groups. 
Hall et al. (1992) 
USA 
Cohort 
General 
Population 
19, 51 (NR), 22-
81; 36.8% 
Relaxation with 
immune based 
imagery, 45 
mins, Individual 
Leukocyte 
count; 
lymphocytes; T-
cells; B-cells; 
Lymphocyte 
response to 
PHA, Con-A, 
and Pokeweed 
(7) 
Significant increases in leukocyte count and 
lymphocyte response to Pokeweed. No significant 
effects on other immune outcomes. 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Hewson-Bower & 
Drummond (1996) 
Australia 
RCT 
Children with and 
without recurrent 
URTIs 
90,  
Children with 
URTIs: 9.4 (NR), 
8-12, 44.4% 
Healthy Children: 
9.7 (NR), 8-12, 
44.6% 
 
a) Relaxation, 
25 mins, 
Group 
b) Relaxation 
with immune 
suggestions, 
25 mins, 
Group 
S-IgA 
concentration; 
S-IgA:albumin 
ratio (2) 
Note: Control condition comprised group 
conversation. 
S-IgA concentration increased significantly 
immediately following both relaxation conditions 
compared to controls. No effects on S-
IgA:Albumin Ratio in any condition. No 
differences between healthy children and those 
with recurrent URT infections. 
Jung et al. (2006) 
South Korea 
RCT 
General 
population 
24, Qi touch 
therapy + rest 
group: 25 (5), NR, 
0% 
Qi non-touch 
therapy + rest 
group: 26 (3), NR, 
0% 
a) Qi touch 
therapy + 
rest, 70 
mins, 
Individual 
b) Qi non-touch 
therapy + 
rest, 70 
mins, 
Individual 
Superoxide 
anions 
produced by 
neutrophils; NK 
cell cytotoxicity 
(2) 
At 10 mins following both interventions NK 
cytotoxicity was significantly increased from pre-
intervention. At 1-hour post-intervention, this 
remained significant only in Qi non-touch therapy 
+ rest condition. Superoxide anion production by 
neutrophils was increased in Qi non-touch 
therapy + rest condition at 10 minutes post-
intervention from pre-intervention but not at 1 
hour. No change in superoxide anion production 
at any time point in Qi-touch therapy + rest 
condition.  
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Kiecolt-Glaser et 
al. (2008) 
USA 
Crossover with 
additional 
randomization  
 
General 
population 
56, 24.4(6.1), 18-
43, 62.5% 
a) Primed 
exposure to 
lemon odour, 
75 mins, 
Individual 
b) Unprimed 
exposure to 
lemon odour 
odour, 75 
mins, 
individual 
c) Primed 
exposure to 
lavender 
odour , 75 
mins, 
Individual 
d) Unprimed 
exposure to 
lavender 
odour , 75 
mins, 
individual 
Delayed 
hypersensitivity 
to Candida; 
lymphocyte 
response to Con 
A x3 
concentrations; 
lymphocyte 
response to 
PHA x3 
concentrations; 
in vitro IL-6 
production; in 
vitro IL-10 
production (9) 
 
Note: this study also included a distilled water 
control condition and exposure to a stressor post-
intervention.  
Smaller maximum and 72-hour wheal size 
following delayed hypersensitivity to Candida test 
in those exposed to lavender odour. No significant 
changes to any of the other immune outcomes 
measured following the interventions. 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Kimata (2004) 
Japan 
Crossover 
Patients with 
atopic dermatitis 
having atopic 
kertoconjuctivitis 
and healthy 
general 
population 
48; Patients: 27 
(NR), 22-43 
General 
population: 26 
(NR), 20-41, 50% 
Comedy Film, 
NR, Group 
Japanese cedar 
pollen-specific 
IgE; Japanese 
cedar pollen-
specific IgG4; 
Japanese cedar 
pollen-specific 
IgA (3) 
In general population, no significant effects of 
intervention as immune outcomes undetectable in 
tears. 
In patients with atopic dermatitis having atopic 
kertoconjuctivitis, there was a significant decrease 
in Japanese cedar pollen-specific IgE and IgG4 
and significant increase in IgA immediately 
following and at 2 hours following the intervention 
compared to baseline, but not at 4 hours. 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Knapp et al. 
(1992) 
USA 
Cohort 
General 
population 
20, NR (NR), NR, 
50% 
Mental recall 
and discussion 
of positive life 
interval with 
interviewer, NR, 
Individual 
Lymphocyte 
response to 
PHA x 2 
concentration; 
Lymphocyte 
response to 
Con-A; 
Lymphocyte 
response to 
Pokeweed; NK 
cell activity, 
leukocyte count, 
PMN cells, 
lymphocytes, 
monocyes, CD-
3%; CD-4%, 
CD-8% (12) 
Significant increase in lymphocyte response to 
low dose PHA immediately following intervention. 
No effects on other immune outcomes. 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Koyama et al. 
(2009) 
Japan 
Cohort 
General 
population young 
and older adults; 
Younger adults: 
27, 27.9 (8.4), 
NR, 70.4% 
Older adults: 
27,70.3 (2.9), NR, 
55.6% 
Drumming, 60 
mins, Group 
NK cell activity; 
leukocyte count; 
neutrophil 
count; 
lymphocyte 
count; T-cell 
count; B-cell 
count; CD-4 
count; CD-8 
count; CD-
4:CD8 ratio; 
Naive T-cell 
count; Memory 
T-cell count; 
NK-cell count; 
IFN-γ; IL-2; IL-4; 
IL-6; IL-10 (18)  
 
In young adults there were no significant changes 
to any of the immune outcomes from before to 
after the intervention.  
In older adults there were significant increases in 
lymphocyte count, T-cell count, CD-4 count, 
Memory T-cell count, IFN-γ production, and IL-6 
production. There were no significant changes in 
any other immune outcome. 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Labott et al. 
(1990) 
USA 
RCT with 
Crossover 
Students who 
considered 
themselves 
expressive 
39, 21.6 (NR), 18-
40, 100%. 
a) Expressing 
emotions 
during a 
Comedy 
Film, 28 
mins, NR 
b) Inhibiting 
emotions 
during a 
comedy 
Film, 28 
mins, NR 
S-IgA 
concentration 
(1) 
Note: A negative mood induction condition 
(negative film) and control group (two neutral 
films) were included in this study.  
Participants asked the inhibit emotions condition 
showed increases in S-IgA concentration from 
before to after the comedy film, however the 
significance of this change was not assessed. In 
the expressing emotions condition, there were no 
differences in S-IgA concentration from before to 
after the comedy film.  
  
Lefcourt et al. 
(1990) 
Canada 
Cohort 
 
Students 
41, NR (NR), NR, 
48.7% 
Comedy 
Audiotape, 30 
mins, Group 
S-IgA 
Concentration 
(1) 
Significant increase in S-IgA concentration from 
before to immediately following intervention. 
Matsunaga et al. 
(2008) 
Japan 
Crossover 
General 
population 
12, NR (NR), 20-
29, 0% 
Film containing 
actresses 
chosen by 
participants as 
attractive, 4 
mins, Individual 
NK cell activity 
(1) 
Note: A neutral control film was included as a 
condition in this study. 
Significant increase in NK cell activity from before 
to immediately post intervention. No change from 
before to after control film. 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Matsunaga et al. 
(2011a) 
Japan 
Crossover 
General 
population 
23; NR (NR), 21-
38, 78.3% 
Odour selected 
by participant to 
invoke positive 
autobiographical 
memory, 90 
seconds, 
Individual 
IL-2; IL-4; IL-6; 
IL-10; TNF-α (5) 
Note: A neutral control odour condition was 
included as a condition in this study. 
No significant changes on any immune outcome 
from before to after odour intervention. IL-2 was 
significantly lower immediately following self-
selected odour intervention compared to 
immediately following control odour.  
 
Matsunaga et al. 
(2011b) 
Japan 
Crossover 
Romantic 
Couples 
14, NR (NR), 21-
38, 50% 
Kissing and 
hugging partner, 
60 mins, 
Couples 
IL-6, TNF-α, 
IFN-γ (3) 
Note: Control condition involved reading quietly 
separately. 
IFN-γ significantly decreased from before to 
immediately after intervention. No changes in IL-6 
or TNF-α. 
 
Matsunaga et al. 
(2013) 
Japan 
Crossover 
General 
population who 
self-report the 
ability to retrieve 
autobiographical 
odour memories 
10, NR (NR), 20-
35, 70% 
Odour selected 
by participant to 
invoke positive 
autobiographical 
memory, 3 x 60 
seconds, 
Individual 
IL-2, IL-5, IL-6, 
IL-10, TNF-α, 
IFN-γ (6) 
Note: A neutral control odour condition was 
included in this study. 
Significant decreases in TNF-α and IFN-γ 
immediately following self-selected odour 
compared to immediately following control odour. 
No differences in other immune outcomes. 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Mittwoch-Jaffe et 
al. (1995) 
Israel 
RCT 
General 
Population 
123, NR (NR), 
NR, 52% 
Comedy film, 45 
mins, Group 
IL-1b, IL-2, IL-3, 
Il-6, TNF-α (5) 
Note: Comparison group watched a horror film for 
matched period of time. 
Significant increase in IL-2, IL-3, and significant 
decrease in TNF-α from before to immediately 
following comedy film intervention. No changes 
on IL-1b and IL-6. 
 
Noto et al. (2010) 
Japan 
Crossover & 
Cohort 
a) General 
Population, 15, 
21.3 (1.1), NR, 
NR 
b) Cancer 
Inpatients 
receiving 
chemotherapy, 
29, 64.6 (12.8), 
NR. 38% 
Leg massage, 
20 mins, 
Individual 
 
S-IgA 
concentration 
(1) 
Note: general population patients also took part in 
a rest control condition for a matched length of 
time. 
S-IgA concentration increased significantly after 
both the intervention and rest for general 
population participants, but no significant 
difference between these. S-IgA concentration 
also increased significantly after leg massage in 
cancer inpatients (this group did not receive the 
rest intervention).  
Pawlow & Jones 
(2005) 
USA 
RCT 
Students, 55, 
24.0 (7.5), 19-57, 
53% 
Abbreviated 
progressive 
relaxation 
training, 25 
mins, Individual 
S-IgA 
concentration; 
S-IgA secretion 
rate (2) 
Note: Control group sat quietly for a matched time 
period. 
Significant increase in S-IgA concentration and 
secretion rate, 5 mins post-intervention. 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Rider et al. (1990) 
USA 
RCT 
Students, 45, NR 
(NR), NR, 56% 
a) Listening to 
music with 
immune 
imagery 
suggestions, 17 
mins, Individual 
b) Listening to 
music with 
unguided 
imagery 
suggestions, 17 
mins, Individual 
S-IgA 
concentration 
(1) 
Note: Control group sat quietly for a matched time 
period. 
S-IgA concentration significantly increased in both 
intervention (a) and (b) above controls, but there 
was no significant difference between (a) and (b). 
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Strauman et al. 
(2004) 
USA 
Crossover 
Students with 
high and low self-
discrepancy 
32, Low-
discrepant: 
19.51(1.58), NR, 
100% 
High-discrepant- 
19.87 (1.41), NR, 
100% 
Writing about 
self-
congruencies, 
20 mins, 
Individual 
Leukocyte 
count; 
lymphocyte 
count; 
lymphocyte %; 
neutrophil 
count; 
neutrophil %; 
CD-3 count; CD-
3 %; CD-4 
count; CD-4 %; 
CD-8 count; CD-
8%; NK cell 
count; NK cell 
%; CD-19 count; 
CD-19%; NK 
cytotoxicity 3x 
concentration; 
lysis per 1000 
NK cells (19) 
 
Note: A negative mood induction condition 
(writing about self-discrepancies) and control 
group (two neutral films) were also part of this 
study. 
In both high and low discrepant students, there 
were significantly higher leukocyte, lymphocyte, 
CD-3, CD-4, CD-8, and NK cell counts 
immediately following self-congruency 
intervention compared to immediately following 
control condition. NK cell count increases were 
significantly higher in high discrepant compared to 
low discrepant students.  
In high discrepant students, lysis per 1000 NK 
cells was also significantly lower immediately 
following self-congruency intervention compared 
to immediately following control condition.  
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Authors 
Origin 
Study Design 
Sample Type 
Sample Size†, 
Mean age (SD), 
Range, Female% 
Intervention 
Description, 
Duration, Mode 
of Delivery 
Immune 
outcome(s) 
measured (n) 
Main Findings 
Takahashi et al. 
(2001) 
Japan 
Crossover 
General 
Population 
21, NR (NR), 18-
26, 0% 
Comedy film, 75 
mins, NR 
NK cell activity 
2x 
concentration; 
CD-16%; CD-
56%; CD-57%; 
leukocyte count; 
(6) 
Note: A neutral control film was included as a 
condition in this study. 
Significant increase in NK cell activity at effector 
to target ratio of 20:1 from before to immediately 
after comedy film intervention, but not following 
control film. No effects on other immune 
outcomes reported.  
Wachi et al. 
(2007) 
Japan 
Crossover 
Yamaha 
Employees 
40, 38.4 (8.4), 
NR, 0% 
Drumming, NR, 
Group 
NK cell activity 
3x 
concentration; 
CD-56%, 
Leukocyte count 
(5)  
Note: A control condition consisting of quite 
reading was included in this study. 
No significant changes in any of the immune 
outcomes assessed because of the intervention.  
 
Yamamoto & 
Nagata (2011) 
Japan 
RCT 
Cancer Patients, 
18, Experimental: 
64.9 (5.8) Control 
(64.2 (8.9), NR, 
33% 
Footbath, 30 
mins, Individual 
S-IgA 
concentration 
(1) 
Note: Controls rested for a matched time period. 
Significant increase in S-IgA concentration from 
pre- to post-intervention. No comparisons 
reported against controls. 
Note:  SD= Standard Deviation; Mins= Minutes; NR= Not Reported; S-IgA = Secretory Immunoglobulin Isotype A; NK= Natural 
Killer; RCT= Randomised Controlled Trial; IL= Interleukin; INF= Interferon; CD= Cluster of Differentiation; PHA= 
phytohaemagglutinin; Con-A= Concanavalin A; URTIs= Upper Respiratory Tract Infections; TNF= Tumor necrosis factor; LPS = 
Lipopolysaccharide; PMN = polymorphonuclear 
† Total study sample size including comparator conditions, if applicable. 
 
 
